Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


New Amedeo service:

Amedeo COVID-19 (formerly 2019-nCoV)

Weekly publication summary


  Neoplasms of the CNS

  Free Subscription


21.12.2019

1 Childs Nerv Syst
1 Clin Neuropathol
1 J Neurooncol
1 Neuro Oncol
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Childs Nerv Syst

  1. SAJID MI, Saleem A, Arshad M, Fadoo Z, et al
    Metachronous translocation renal cell carcinoma in a child with successfully treated medulloblastoma.
    Childs Nerv Syst. 2019 Dec 14. pii: 10.1007/s00381-019-04447.
    PubMed     Text format     Abstract available


    Clin Neuropathol

  2. VIDAL B, Bryke C, Hsu N, Alterman R, et al
    A high-grade glioma with SOS1 amplification.
    Clin Neuropathol. 2019 Dec 16. pii: NP301182. doi: 10.5414/NP301182.
    PubMed     Text format     Abstract available


    J Neurooncol

  3. MARTINS F, Schiappacasse L, Levivier M, Tuleasca C, et al
    The combination of stereotactic radiosurgery with immune checkpoint inhibition or targeted therapy in melanoma patients with brain metastases: a retrospective study.
    J Neurooncol. 2019 Dec 14. pii: 10.1007/s11060-019-03363.
    PubMed     Text format     Abstract available


    Neuro Oncol

  4. ARNOLD A, Yuan M, Price A, Harris L, et al
    Synergistic activity of mTORC1/2 kinase and MEK inhibitors suppresses pediatric low-grade glioma tumorigenicity and vascularity.
    Neuro Oncol. 2019 Dec 16. pii: 5679447. doi: 10.1093.
    PubMed     Text format     Abstract available


    PLoS One

  5. MAITI P, Plemmons A, Dunbar GL
    Combination treatment of berberine and solid lipid curcumin particles increased cell death and inhibited PI3K/Akt/mTOR pathway of human cultured glioblastoma cells more effectively than did individual treatments.
    PLoS One. 2019;14:e0225660.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: